LEAH BARBEE: Open Payments
NPI 1811170566 · MILLEDGEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,588 in 86 payments from 26 companies in 2025. Trend: 2023 $2,041 · 2024 $3,404 · 2025 $1,588
Food & beverage: $1,588
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $255 |
| Amgen Inc. | 20 | $251 |
| Insulet Corporation | 7 | $169 |
| Novartis Pharmaceuticals Corporation | 7 | $118 |
| Corcept Therapeutics | 6 | $110 |
| SANOFI-AVENTIS U.S. LLC | 4 | $90 |
| Abbott Laboratories | 4 | $71 |
| Tandem Diabetes Care, Inc. | 3 | $69 |
| CeQur Corporation | 1 | $60 |
| TOLMAR, INC. | 3 | $52 |
Products named: TEPEZZA, Omnipod, Ozempic, LEQVIO, Korlym, TZIELD, Wegovy, FREESTYLE LIBRE.
Industry payments across GA — which companies pay providers there.
